Robert Kushner, a renowned author and professor at Northwestern University's Feinberg School of Medicine, dives into the latest advancements in obesity treatment. He discusses new FDA-approved medications, such as semaglutide and terzepatide, highlighting their effectiveness and side effects. Kushner emphasizes the importance of treating obesity as a chronic disease, the potential implications of stopping medication, and the need for gradual dose adjustments. This insightful conversation sheds light on the evolving landscape of obesity management.

Dr. Deborah Horn and Dr. Robert Kushner discuss challenges and solutions in obesity management with Dr. Neil Skolnik. They cover topics such as tailored care, pharmacotherapy, muscle loss prevention, body composition in older adults, weight management for diabetic patients, and the collaborative approach to treating obesity in primary care.